Literature DB >> 31622775

The long noncoding RNA Crnde regulates osteoblast proliferation through the Wnt/β-catenin signaling pathway in mice.

Mieradili Mulati1, Yutaka Kobayashi1, Akira Takahashi1, Hoashi Numata1, Masanori Saito1, Yuichi Hiraoka2, Hiroki Ochi1, Shingo Sato1, Yoichi Ezura3, Masato Yuasa1, Takashi Hirai1, Toshitaka Yoshii1, Atsushi Okawa1, Hiroyuki Inose4.   

Abstract

In the past decade, a growing importance has been placed on understanding the significance of long noncoding RNAs (lncRNAs) in regulating development, metabolism, and homeostasis. Osteoblast proliferation and differentiation are essential elements in skeletal development, bone metabolism, and homeostasis. However, the underlying mechanisms of lncRNAs in the process of osteoblast proliferation and differentiation remain largely unknown. Through comprehensive analysis of lncRNAs during bone formation, we show that colorectal neoplasia differentially expressed (Crnde), previously viewed as a cancer-related lncRNA, is an important regulator of osteoblast proliferation and differentiation. Crnde was found to be expressed in osteoblasts, and its expression was induced by parathyroid hormone. Furthermore, Crnde knockout mice developed a low bone mass phenotype due to impaired osteoblast proliferation and differentiation. Overexpression of Crnde in osteoblasts promoted their proliferation, and conversely, reduced Crnde expression inhibited osteoblast proliferation. Although ablation of Crnde inhibited osteoblast differentiation, overexpression of Crnde restored it. Finally, we provided evidence that Crnde modulates bone formation through Wnt/β-catenin signaling. Therefore, our data suggest that Crnde is a novel regulator of bone metabolism.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Noncoding RNA; Osteoblast; Osteoporosis; Parathyroid hormone; Proliferation; Wnt signaling

Mesh:

Substances:

Year:  2019        PMID: 31622775     DOI: 10.1016/j.bone.2019.115076

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  11 in total

1.  LncRNA CRNDE hinders the progression of osteoarthritis by epigenetic regulation of DACT1.

Authors:  Ziqi Zhang; Pei Yang; Chunsheng Wang; Run Tian
Journal:  Cell Mol Life Sci       Date:  2022-07-08       Impact factor: 9.207

Review 2.  New Emerging Biomarkers for Bone Disease: Sclerostin and Dickkopf-1 (DKK1).

Authors:  Aylin Sepinci Dincel; Niklas Rye Jørgensen
Journal:  Calcif Tissue Int       Date:  2022-09-27       Impact factor: 4.000

3.  Foxf2 represses bone formation via Wnt2b/β-catenin signaling.

Authors:  Tomoyuki Tanaka; Akira Takahashi; Yutaka Kobayashi; Masanori Saito; Sun Xiaolong; Chen Jingquan; Yoshiaki Ito; Tsuyoshi Kato; Hiroki Ochi; Shingo Sato; Toshitaka Yoshii; Atsushi Okawa; Peter Carlsson; Hiroyuki Inose
Journal:  Exp Mol Med       Date:  2022-06-06       Impact factor: 12.153

4.  LncRNA RP1-85F18.6 affects osteoblast cells by regulating the cell cycle.

Authors:  Jiangtao Song; Wenrong Song; Lei Zhang
Journal:  Open Life Sci       Date:  2020-12-22       Impact factor: 0.938

5.  Long non-coding RNA TUG1 knockdown repressed the viability, migration and differentiation of osteoblasts by sponging miR-214.

Authors:  Zhitao Yao; Wei An; Adili Moming; Maimaitituxun Tuerdi
Journal:  Exp Ther Med       Date:  2022-01-07       Impact factor: 2.447

6.  Long noncoding RNA Lnc-DIF inhibits bone formation by sequestering miR-489-3p.

Authors:  Chong Yin; Ye Tian; Dijie Li; Yang Yu; Shanfeng Jiang; Yimei Hou; Meng Deng; Kaiyuan Zheng; Yan Zhang; Xiaoni Deng; Zhihao Chen; Zhiping Miao; Qiang Hao; Yu Li; Airong Qian
Journal:  iScience       Date:  2022-02-21

Review 7.  CRNDE: A valuable long noncoding RNA for diagnosis and therapy of solid and hematological malignancies.

Authors:  Xuefei Ma; Wen Jin; Chaoxian Zhao; Xuefeng Wang; Kankan Wang
Journal:  Mol Ther Nucleic Acids       Date:  2022-03-09       Impact factor: 8.886

Review 8.  Reverse-genetics studies of lncRNAs-what we have learnt and paths forward.

Authors:  Fan Gao; Ye Cai; Philipp Kapranov; Dongyang Xu
Journal:  Genome Biol       Date:  2020-04-14       Impact factor: 13.583

9.  Silencing of lncRNA AK045490 Promotes Osteoblast Differentiation and Bone Formation via β-Catenin/TCF1/Runx2 Signaling Axis.

Authors:  Dijie Li; Ye Tian; Chong Yin; Ying Huai; Yipu Zhao; Peihong Su; Xue Wang; Jiawei Pei; Kewen Zhang; Chaofei Yang; Kai Dang; Shanfeng Jiang; Zhiping Miao; Meng Li; Qiang Hao; Ge Zhang; Airong Qian
Journal:  Int J Mol Sci       Date:  2019-12-10       Impact factor: 5.923

Review 10.  Effects of miRNAs, lncRNAs and circRNAs on osteoporosis as regulatory factors of bone homeostasis (Review).

Authors:  Zhichao Li; Haipeng Xue; Guoqing Tan; Zhanwang Xu
Journal:  Mol Med Rep       Date:  2021-09-10       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.